Chemically modified chitosan as a functional biomaterial for drug delivery system

被引:0
|
作者
Sajeev, Devika [1 ]
Rajesh, Aparna [1 ]
Kumaar, R. Nethish [1 ]
Aswin, D. [1 ]
Jayakumar, Rangasamy [2 ]
Nair, Sreeja C. [1 ]
机构
[1] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Kochi 682041, Kerala, India
[2] Amrita Vishwa Vidyapeetham, Sch Nanosci & Mol Med, Polymer Biomat Lab, Kochi 682041, India
关键词
Chemically modified chitosan; Biomaterial; Drug delivery; Targeted drug delivery; Nanoparticle; Hydrogel; Composites; Scaffolds; IN-VIVO EVALUATION; ORAL DELIVERY; NANOPARTICLES; DERIVATIVES; RELEASE; PROTEIN; ANTIBACTERIAL; SCAFFOLD; SMART; VITRO;
D O I
10.1016/j.carres.2024.109351
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chitosan is a natural polymer that can degrade in the environment and support green chemistry. It displays superior biocompatibility, easy access, and easy modification due to the reactive amino groups to transform or improve the physical and chemical properties. Chitosan can be chemically modified to enhance its properties, such as water solubility and biological activity. Modified chitosan is the most effective functional biomaterial that can be used to deliver the drugs to the targeted site. With diverse and versatile characteristics, it can be fabricated into various drug delivery systems such as membranes, beads, fibers, microparticles, composites, and scaffolds, for different drug delivery methods. Integrating nanotechnology with modified chitosan enhanced the delivery attributes of antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, protein/peptides, and nucleic acids for intended use toward desired therapeutic outcomes. The review brings out an overview of the research regarding drug delivery systems utilizing modifying chitosan detailing the properties, functionality, and applications.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery
    Gao, Weiwei
    Zhang, Yue
    Zhang, Qiangzhe
    Zhang, Liangfang
    ANNALS OF BIOMEDICAL ENGINEERING, 2016, 44 (06) : 2049 - 2061
  • [32] CHEMICALLY MODIFIED COLLAGEN - A NATURAL BIOMATERIAL FOR TISSUE REPLACEMENT
    NIMNI, ME
    CHEUNG, D
    STRATES, B
    KODAMA, M
    SHEIKH, K
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1987, 21 (06): : 741 - 771
  • [33] Chemically Modified Gelatin as Biomaterial in the Design of New Nanomedicines
    Lopez-Cebral, Rita
    Martin-Pastor, M.
    Evelin Parraga, Jenny
    Konat Zorzi, Giovanni
    Seijo, Begona
    Sanchez, Alejandro
    MEDICINAL CHEMISTRY, 2011, 7 (03) : 145 - 154
  • [34] Degradation of chitosan and chemically modified chitosan by viscosity measurements
    Agnihotri, Sunil A.
    Kulkarni, Vaibhav D.
    Kulkarni, Anandrao R.
    Aminabhavi, Tejraj M.
    Journal of Applied Polymer Science, 2006, 102 (04): : 3255 - 3258
  • [35] Degradation of chitosan and chemically modified chitosan by viscosity measurements
    Agnihotri, Sunil A.
    Kulkarni, Vaibhav D.
    Kulkarni, Anandrao R.
    Aminabhavi, Tejraj M.
    JOURNAL OF APPLIED POLYMER SCIENCE, 2006, 102 (04) : 3255 - 3258
  • [36] Chitosan Mediated Targeted Drug Delivery System: A Review
    Patel, Manish P.
    Patel, Ravi R.
    Patel, Jayvadan K.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (04): : 536 - 557
  • [37] Chitosan Nanoparticles as a Percutaneous Drug Delivery System for Hydrocortisone
    Katas, Haliza
    Hussain, Zahid
    Ling, Tay Chai
    JOURNAL OF NANOMATERIALS, 2012, 2012
  • [38] Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
    Nagpal, Kalpana
    Singh, Shailendra Kumar
    Mishra, Dina Nath
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (11) : 1423 - 1430
  • [39] Chitosan-Halloysite Hydrogel Drug Delivery System
    Luo, Yangyang
    Mills, David K.
    2016 32ND SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE (SBEC), 2016, : 76 - 77
  • [40] Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system
    Krauland, Alexander H.
    Alonso, Maria Jose
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 340 (1-2) : 134 - 142